National Health Investors, Inc. (NYSE:NHI) – Research analysts at Cantor Fitzgerald issued their FY2017 earnings estimates for shares of National Health Investors in a research note issued to investors on Tuesday. Cantor Fitzgerald analyst J. France forecasts that the real estate investment trust will earn $5.23 per share for the year. Cantor Fitzgerald also issued estimates for National Health Investors’ FY2018 earnings at $5.46 EPS.

National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the consensus estimate of $1.29 by $0.36. The business had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm’s revenue was up 14.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.22 EPS.

TRADEMARK VIOLATION NOTICE: “Cantor Fitzgerald Weighs in on National Health Investors, Inc.’s FY2017 Earnings (NHI)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.watchlistnews.com/cantor-fitzgerald-weighs-in-on-national-health-investors-inc-s-fy2017-earnings-nhi/1546064.html.

Other research analysts also recently issued research reports about the company. BidaskClub raised National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, June 29th. Stifel Nicolaus upped their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Wednesday, May 10th. Finally, ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $81.40.

National Health Investors (NYSE:NHI) opened at 80.10 on Thursday. The firm has a market capitalization of $3.28 billion, a PE ratio of 20.57 and a beta of 0.56. National Health Investors has a 12 month low of $66.31 and a 12 month high of $82.11. The stock’s 50 day moving average price is $77.93 and its 200 day moving average price is $75.70.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be given a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.74%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s dividend payout ratio is currently 97.69%.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the sale, the insider now owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a filing with the SEC, which is available through this link. 5.19% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in NHI. Carroll Financial Associates Inc. bought a new stake in shares of National Health Investors in the 2nd quarter valued at $158,000. Quantbot Technologies LP bought a new stake in shares of National Health Investors in the 1st quarter valued at $201,000. Yorktown Management & Research Co Inc bought a new stake in shares of National Health Investors in the 2nd quarter valued at $214,000. Allegis Investment Advisors LLC bought a new stake in shares of National Health Investors in the 2nd quarter valued at $216,000. Finally, Daiwa Securities Group Inc. increased its position in shares of National Health Investors by 1.7% in the 1st quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 70.58% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.